Adimab logo

Adimab

Premier Human Antibody Discovery and Engineering Company

137 employees · est. 2007 · Lebanon, United States

VS
AlivaMab Biologics logo

AlivaMab Biologics

Superior Antibody Therapeutics

32 employees · est. 2018 · San Diego, United States

Adimab is the older company (2007 vs 2018); Adimab is the larger of the two.

Side-by-Side Comparison

Adimab AlivaMab Biologics
Founded
2007 older 2018
Headquarters
Lebanon, United States San Diego, United States
Employees
137 larger 32
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health and Wellness
Funding Stage
Series Unknown Not tracked yet
Total Funding
Not tracked yet Not tracked yet
Funding Rounds
8 Not tracked yet
Services
Antibody Discovery Platform, Antibody Engineering, Protein and TCR Engineering, Multispecific Antibodies, Funded Discovery, Platform Transfer Not tracked yet
Target Customers
Biopharmaceutical Companies, Biotechnology Firms, Clinical Research Organizations, Drug Development Teams, Pharmaceutical Manufacturers Not tracked yet
Taxonomy
Antibody Discovery, Biopharmaceutical Collaborations, Yeast-Based Platform, Antibody Engineering, Therapeutic Leads, Protein Modality Development, T Cell Engagers, Fc & Fab Heterodimerization, Custom Antibody Discovery, Chain Exchange Technology, AI & ML Guided Library Design, Soluble TCR Optimization, Bi- & Multispecific Antibodies, Antibody Optimization, Therapeutics Pipeline Expansion Biologics Drug Discovery, Antibody Therapeutics, Biologic Drug Modalities, Antibody Engineering, Monoclonal Antibody Discovery, Bispecific Antibodies, Antibody Drug Conjugates, Functional Antibody Leads, Transgenic Mouse, Immunization Techniques, Protein Expression, Purification, Developability Assessment, Functional Assay Development, Kinetic And Epitope Characterization
Website
adimab.com alivamab.com
Adimab logo

About Adimab

Adimab, founded in 2007, positions itself as a premier player in antibody discovery and engineering, serving as a favored partner within the biopharma sector. The company leverages a proprietary yeast-based platform, which facilitates the comprehensive discovery and optimization of human antibodies...

AlivaMab Biologics logo

About AlivaMab Biologics

AlivaMab Biologics is a biotechnology startup founded in 2018, focusing on providing fully integrated solutions for biologics drug discovery. The company's customizable capability modules encompass target validation, tool engineering and production, assay development, discovery of binding domains us...

We will tell you when either one moves

BounceWatch watches Adimab and AlivaMab Biologics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Adimab and AlivaMab Biologics — by email.

Frequently Asked Questions

Adimab — Premier Human Antibody Discovery and Engineering Company. AlivaMab Biologics — Superior Antibody Therapeutics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Adimab and AlivaMab Biologics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Adimab with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Adimab on 16 Jun 2026, and AlivaMab Biologics on 15 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes